Abstract
The anthelmintic pyrantel plays an important role in the control of gastrointestinal helminths of humans and domestic animals. Despite the demonstration of pyrantel resistance in several helminth species over the last 20 years, the resistance mechanism remains unclear. It has been hypothesized that resistance may arise as a consequence of changes to the relative proportions of subpopulations of nicotinic acetylcholine receptors (nAchRs). To test this hypothesis, we examined the responses of two isolates of the canine hookworm Ancylostoma caninum with low-level resistance (isolate NT) and high-level resistance (isolate PR) to pyrantel to nicotinic agonist drugs reported to be selective for three nAchR subtypes. We used larval motility and conformation assays and force transduction experiments with adult worms. Pyrantel and levamisole were less potent against larvae of isolate PR than larvae of isolate NT (up to an 18-fold increase in the 50% inhibitory concentration); on the other hand, bephenium was more potent against larvae of isolate PR than larvae of isolate NT (twofold) and nicotine had the same potency against larvae of both isolates. In adults, pyrantel, levamisole, and nicotine were less potent against isolate PR than i...Continue Reading
References
Oct 1, 1991·International Journal for Parasitology·N C SangsterG H Collins
May 1, 1987·Veterinary Parasitology·A RoepstorffP Nansen
Feb 1, 1972·Proceedings of the Society for Experimental Biology and Medicine·H L Howes
Apr 1, 1994·Veterinary Parasitology·D E JacobsO Vanparijs
Jul 1, 1997·The Veterinary Journal·R J Martin
Mar 11, 1998·Acta Tropica·J A ReynoldsonR C Thompson
Mar 30, 1999·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A P RobertsonR J Martin
Aug 26, 1999·Nature Neuroscience·J E Richmond, E M Jorgensen
Sep 29, 1999·International Journal for Parasitology·A C KotzeR J Dobson
Jul 13, 2000·Veterinary Parasitology·M B PetersenP Nansen
Aug 17, 2002·The Journal of Pharmacology and Experimental Therapeutics·Alan P RobertsonRichard J Martin
Dec 30, 2003·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Andrew K Jones, David B Sattelle
Aug 18, 2004·International Journal for Parasitology·Richard J MartinAlan P Robertson
Dec 1, 1987·New Zealand Veterinary Journal·R JacksonK Stewart
Jul 23, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jeffrey BethonyPeter J Hotez
Mar 30, 2006·Parasitology·N C SangsterJ Demeler
May 9, 2006·Lancet·Jeffrey BethonyPeter J Hotez
Oct 3, 2006·Veterinary Parasitology·Steven R KoppGlen T Coleman
Jul 5, 2007·Parasitology·R J Martin, A P Robertson
Aug 28, 2007·The Veterinary Journal·Steven R KoppGlen T Coleman
Oct 24, 2007·Invertebrate Neuroscience : in·Sally M WilliamsonAdrian J Wolstenholme
Feb 5, 2008·Veterinary Parasitology·Steven R KoppAndrew C Kotze
Mar 14, 2008·Nature·Ronald KaminskyPascal Mäser
Citations
Apr 25, 2012·Invertebrate Neuroscience : in·Claude L CharvetCédric Neveu
Jan 5, 2014·Journal of Parasitology Research·Matheus Diniz Gonçalves CoêlhoIsmael Maciel de Mancilha
May 28, 2013·Parasitology International·Sandra M MiltschGeorg von Samson-Himmelstjerna
Dec 1, 2012·International Journal for Parasitology. Drugs and Drug Resistance·Lucienne TrittenJennifer Keiser
Jan 3, 2012·Acta Tropica·Lucienne TrittenJennifer Keiser
Dec 11, 2019·Parasites & Vectors·Pablo D Jimenez CastroRay M Kaplan
Jun 3, 2021·Pharmaceuticals·Sasa M TrailovicClaude L Charvet